4. Intuitive Surgical Inc. (NASDAQ:ISRG)
Intuitive Surgical, Inc. (NASDAQ: ISRG) takes fourth place as the most financially established medical-technology company in the ranking.
The company is the global leader in robotic-assisted surgery through its da Vinci surgical systems. Hospitals purchase or lease the systems and then generate recurring revenue for the company by buying instruments, accessories and services.
Artificial intelligence, surgical data and advanced imaging can make the platform more valuable over time. The company’s systems generate large amounts of procedural information that can support surgeon training, workflow analysis, clinical decision-making and future automation.
Second-quarter 2026 revenue increased 19% year over year to $2.89 billion. Adjusted earnings reached $2.80 per share and exceeded market expectations.
Worldwide procedure growth using the da Vinci platform remained strong, although management maintained its full-year forecast of approximately 13.5% to 15.5%. The decision not to increase that outlook disappointed investors who had expected another upward revision.
Intuitive Surgical, Inc. (NASDAQ: ISRG) has advantages that emerging healthcare AI stocks cannot easily replicate. These include an extensive installed base, long-standing hospital relationships, substantial recurring revenue and decades of procedural data.
It is also profitable and financially capable of investing through economic downturns. That makes it considerably less speculative than smaller AI healthcare companies still depending on external financing.
The principal concern is valuation. The market has historically awarded the company a premium because of its leadership position and dependable growth. When expectations are elevated, even strong financial results can cause the share price to decline if management’s outlook appears conservative.
Its fourth-place position reflects a deliberate balance. The company may not have the highest revenue growth rate or the purest AI investment story, but it offers one of the strongest combinations of commercial durability, healthcare technology and long-term innovation.
